Inflammation and Coagulation are Two Interconnected Pathophysiological Pathways in Atrial Fibrillation Pathogenesis

References

• Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham heart study. Circulation. 2004;110(9):1042–1046. doi:10.1161/01.cir.0000140263.20897.42
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612
   PubMed Web of Science ®Google Scholar
• N. GA, P. CD, Hartshorne T, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37(20):1591–1602. doi:10.1093/eurheartj/ehw007
   PubMed Web of Science ®Google Scholar
• Chao TF, Liao JN, Tuan TC, et al. Incident co-morbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): implications for reassessment of stroke risk n initially ‘low-risk’ patients. Thromb Haemost. 2019;119:1162–1170. doi:10.1055/s-0039-1683933
   PubMed Web of Science ®Google Scholar
• Bone ED, Goode A, Raitz G, et al. Sender G.D Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review. Thromb Haemost. 2018;118:2171–2187. doi:10.1055/s-0038-1675400
   PubMed Web of Science ®Google Scholar
• Harada M, Van Wagoner DR, Nattel S. Role of inflammation in atrial fibrillation pathophysiology and management. Circulation. 2015;79(3):495–502. doi:10.1253/circj.CJ-15-0138
   Web of Science ®Google Scholar
• Choi YJ, Choi EK, Han KD, et al. Increased risk of atrial fibrillation in patients with inflammatory bowel disease: a nationwide population-based study. World J Gastroenterol. 2019;25(22):2788–2798. doi:10.3748/wjg.v25.i22.2788
   PubMed Web of Science ®Google Scholar
• Cianfrocca C, Loricchio ML, Pelliccia F, et al. C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillation. Int J Cardiol. 2010;142:22–28. doi:10.1016/j.ijcard.2008.12.052
   PubMed Web of Science ®Google Scholar
• Li YG, Lee SR, Choi EK, G.y L. Stroke prevention in atrial fibrillation: focus on Asian patients. Korean Circ J. 2018;48:665–684. doi:10.4070/kcj.2018.0190
   PubMed Web of Science ®Google Scholar
• Foley JH, Conway EM. Cross talk pathways between coagulation and inflammation. Circ Res. 2016;118:1392–1408. doi:10.1161/CIRCRESAHA.116.306853
   PubMed Web of Science ®Google Scholar
• Lin KB, Fan FH, Cai MQ, et al. Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke. Eur J Med Res. 2022;27(1):106. doi:10.1186/s40001-022-00733-9
   PubMed Web of Science ®Google Scholar
• Mailer RK, Rangaswamy C, Konrath S, Emsley J, Renné TH. An update on factor XII-driven vascular inflammation. Biochim Biophys Acta Mol Cell Res. 2022;1869(1):119166. doi:10.1016/j.bbamcr.2021.119166
   PubMed Web of Science ®Google Scholar
• Ma L, Willey J. The interplay between inflammation and thrombosis in COVID-19: mechanisms, therapeutic strategies, and challenges. Thrombosis Update. 2022;8:100117. doi:10.1016/j.tru.2022.100117
   PubMedGoogle Scholar
• Zhu S, Lin Y, Zhang Y, et al. Prognostic relevance of left atrial function and stiffness in heart failure with preserved ejection fraction patients with and without diabetes mellitus. Front Cardiovasc Med. 2022;14:947639. doi:10.3389/fcvm.2022.947639.;
   Google Scholar
• Brandes A, Smit MD, Nguyen BO, Rienstra M, Van Gelder IC. Risk factor management in atrial fibrillation. Arrhythm Electrophysiol Rev. 2018;7(2):118–127. doi:10.15420/aer.2018.18.2
   PubMed Web of Science ®Google Scholar
• Jones NR, Taylor KS, Taylor CJ, Aveyard P. Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis. Heart. 2019;105(23):1799–1805. doi:10.1136/heartjnl-2019-314931
   PubMed Web of Science ®Google Scholar
• Ogunsua AA, Shaikh AY, Ahmed M, McManus DD. Atrial fibrillation and hypertension: mechanistic, epidemiologic, and treatment parallels. Methodist DeBakey Cardiovasc J. 2015;11(4):228–234. doi:10.14797/mdcj-11-4-228
   PubMedGoogle Scholar
• Kim YG, Han K, Choi JI, et al. Frequent drinking is a more important risk factor for new-onset atrial fibrillation than binge drinking: a nationwide population-based study. EP Europace. 2020;22(2):216–224. doi:10.1093/europace/euz256
   PubMed Web of Science ®Google Scholar
• Csengeri D, Sprünker NA, Castelnuovo AD, et al. Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes.European. Heart Journal. 2021;42(12):1170–1177. doi:10.1093/eurheartj/ehaa953
   PubMed Web of Science ®Google Scholar
• Lee KWJ, Hill JS, Walley KR, et al. Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort. CMAJ. 2006;174:461–466. doi:10.1503/cmaj.050880
   PubMed Web of Science ®Google Scholar
• Ihara K, Sasano T. Role of inflammation in the pathogenesis of atrial fibrillation. Front Physiol. 2022;13:862164. doi:10.3389/fphys.2022.862164
   PubMed Web of Science ®Google Scholar
• Yao Y, Yang M, Liu D, et al. Immune remodeling and atrial fibrillation. Front Physiol. 2022;13:927221. doi:10.3389/fphys.2022.927221
   PubMed Web of Science ®Google Scholar
• Boss CHJ, Anderson RA, Lip GYH. Is atrial fibrillation an inflammatory disorders? Eur Heart J. 2006;27:136–149. doi:10.1093/eurheartj/ehi645
   PubMedGoogle Scholar
• Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003;108(24):3006–3010. doi:10.1161/01.CIR.0000103131.70301.4F
   PubMed Web of Science ®Google Scholar
• Boyalla V, Harling L, Snell A, et al. Biomarkers as predictors of recurrence of atrial fibrillation post ablation: an updated and expanded systematic review and meta-analysis. Clin Res Cardiol. 2022;111(6):680–691. doi:10.1007/s00392-021-01978-w
   PubMed Web of Science ®Google Scholar
• Pauklin P, Zilmer M, Eha J, Tootsi K, Kals M, Kampus P. Markers of inflammation, oxidative stress, and fibrosis in patients with atrial fibrillation. Oxid Med Cell Longev. 2022;2022:4556671. doi:10.1155/2022/4556671
   PubMed Web of Science ®Google Scholar
• Terrell AM, Crisostomo PR, Wairiuko GM, Wang M, Morrell ED, Meldrum DR. Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock. 2006;26:226–234. doi:10.1097/01.shk.0000226341.32786.b9
   PubMed Web of Science ®Google Scholar
• Fontes JA, Rose NR, Čiháková D. The varying faces of IL-6: from cardiac protection to cardiac failure. Cytokine. 2015;74(1):62–68. doi:10.1016/j.cyto.2014.12.024
   PubMed Web of Science ®Google Scholar
• Su JH, Luo MY, Liang N, et al. Interleukin-6: a novel target for cardio-cerebrovascular diseases. Front Pharmacol. 2021;12:745061. doi:10.3389/fphar.2021.745061
   PubMed Web of Science ®Google Scholar
• Wu N, B. X, Xiang Y, et al. Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis. Int J Cardiol. 2013;169(1):62–72. doi:10.1016/j.ijcard.2013.08.078
   PubMed Web of Science ®Google Scholar
• Dobrev D, Heijman J, Hiram R, et al. Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology. Nat Rev Cardiol. 2023;20:145–167. doi:10.1038/s41569-022-00759-w
   PubMed Web of Science ®Google Scholar
• Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with atrial fibrillation: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66(8):943–959. doi:10.1016/j.jacc.2015.06.1313
   PubMed Web of Science ®Google Scholar
• Jalife J, Kaur K. Atrial remodeling, fibrosis, and atrial fibrillation. Trends Cardiovasc Med. 2015;25(6):475–484. doi:10.1016/j.tcm.2014.12.015
   PubMed Web of Science ®Google Scholar
• Nso N, Kaveh R, Bookani MM, Radparvar F. Role of inflammation in atrial fibrillation: a comprehensive review of current knowledge. J Arrhythmia. 2021;37:1. doi:10.1002/joa3.12473
   PubMed Web of Science ®Google Scholar
• Guzel T, Kış M, Şenöz O. The correlation between the left atrial volume index and atrial fibrillation development in heart failure with mildly reduced ejection fraction and long-term follow-up results. Acta Cardiol. 2022;77(7):647–654. doi:10.1080/00015385.20222.2067674
   PubMed Web of Science ®Google Scholar
• Aulin J, Siegbahn A, Hijazi Z, et al. Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. Am Heart J. 2015;170(6):1151–1160. doi:10.1016/j.ahj.2015.09.018
   PubMed Web of Science ®Google Scholar
• Li X, Peng S, Wu X, et al. C-reactive protein and atrial fibrillation: insights from epidemiological and Mendelian randomization studies Meta-Analysis. Nutr Metab Cardiovasc Dis. 2022;32(6):1519–1527. doi:10.1016/j.numecd
   PubMed Web of Science ®Google Scholar
• Vojacek JF. Should we replace the terms intrinsic and extrinsic coagulation pathways with tissue factor pathway? Clin Appl Thromb Hemost. 2017;23(8):922–927. doi:10.1177/1076029616673733
   PubMed Web of Science ®Google Scholar
• Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18:666–682. doi:10.1038/s41569-021-00552-1
   PubMed Web of Science ®Google Scholar
• Yau JW, Teoh H, Verma S. Endothelial cell control of thrombosis. BMC Cardiovasc Disord. 2015;15:130. doi:10.1186/s12872-015-0124-z
   PubMed Web of Science ®Google Scholar
• D’Alessandro E, Posma JJN, Spronk HMH, Ten Cate H. Tissue factor (Factor VIIa) in the heart and vasculature: more than an envelope. Thromb Res. 2018;168:130–137. doi:10.1016/j.thromres.2018.06.020
   PubMed Web of Science ®Google Scholar